Form 4: LeMaitre Vascular CEO Sells 46,481 Shares
Statement of Changes in Beneficial Ownership
Chairman and CEO George W. LeMaitre sold 46,481 shares of common stock over two days in May 2026.
Summary
- George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, Inc., sold a total of 46,481 shares of common stock.
- The sales occurred on May 7, 2026, and May 8, 2026.
- 18,600 shares were sold at a weighted average price of $107.6351 on May 7.
- 27,881 shares were sold at a weighted average price of $108.6905 on May 8.
- Following these transactions, the reporting person maintains direct ownership of 1,430,019 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event; while insider selling can be viewed negatively, it is a routine disclosure of personal financial management by an executive.
Positives
- The CEO retains a significant equity stake of 1,430,019 shares, indicating continued alignment with shareholder interests.
Negatives
- The sale of a substantial block of shares by the CEO may be perceived by some investors as a lack of confidence in the short-term stock price appreciation.
Risks
- Insider selling can sometimes create downward pressure on the stock price or signal to the market that the stock is fully valued.
Future Outlook
No specific forward-looking guidance or operational outlook was provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling by high-level executives is a common occurrence for liquidity or personal financial planning and does not necessarily reflect a change in the company's fundamental business health.
Comparison to Industry Standards
- Insider sales by CEOs of mid-cap medical device companies are standard practice and often occur periodically for diversification purposes.
Related Party Transactions
- The reporting person holds 33,400 shares in the LeMaitre Irrevocable Life Insurance Trust of 2025 for the benefit of his children.
Stakeholder Impact
- Shareholders may monitor the stock price for volatility following the disclosure of significant insider selling.
Key Dates
| Date | Description |
|---|---|
| 05/07/2026 | First date of share sales by the reporting person. |
| 05/08/2026 | Second date of share sales by the reporting person. |
| 05/11/2026 | Date of filing for the Form 4. |
Keywords
LeMaitre Vascular, LMAT, Insider Trading, Form 4, George LeMaitre, Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.